Katharina, Nora STEINITZ,Paula, Maria WILHELMINA VAN HELDEN,Birgit, Maria REIPERT,Hans-Peter SCHWARZ,Hartmut EHRLICH
申请号：
HK16103339.6
公开号：
HK1215442A
申请日:
2016.03.22
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention is related to peptides that can be used to reduce the immune response against FVIII or to induce tolerance to human FVIII in patients with, e. g., hemophilia A. Furthermore, the peptides can be used for immunodiagnostic purposes to detect FVIII-specific CD4 + T cells to monitor patients with hemophilia A during replacement therapy and during immune tolerance induction therapy.
